Filing Details
- Accession Number:
- 0001209191-20-009700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-14 16:43:30
- Reporting Period:
- 2019-12-16
- Accepted Time:
- 2020-02-14 16:43:30
- SEC Url:
- Form 4 Filing
Issuer
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1015994 | R Paul Gudonis | C/O Myomo, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-16 | 1,333 | $0.00 | 18,800 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2020-02-13 | 1,333 | $0.00 | 20,133 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2020-02-13 | 6,000 | $6.99 | 26,133 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2020-02-13 | 6,000 | $0.01 | 6,000 | $7.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
6,000 | 2020-02-13 | 2025-02-13 | No | 4 | P | Direct |
Footnotes
- Reporting person was previously granted restricted stock units that may be settled into an aggregate of 6,666 shares of common stock. Upon the achievement of performance criteria, portions of the restricted stock unit grant will commence time-based vesting. The performance criteria for the restricted stock units described in this Report were met and such portion will vest in equal installments on September 25, 2020 and 2021.
- Shares beneficially owned by this reporting person have been adjusted to reflect a one-for-thirty reverse stock split effected on January 30, 2020.
- Represents the purchase of common stock and related investor warrant as part of the Company's underwritten public offering, which was completed on February 13, 2020. The investor warrant has an exercise price of $7.50 per share and expires five years from the date of issuance.